Arch Biopartners Market Cap

Arch Biopartners has a market cap or net worth of $21.11 million as of April 29, 2026. Its market cap has decreased by -75.73% in one year.

Market Cap

21.11M

Enterprise Value

23.03M

Revenue

115.29K

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.33

Market Cap Chart

Since January 21, 2011, Arch Biopartners's market cap has decreased from 33.63M to 21.11M, a decrease of -37.21%. That is a compound annual growth rate of -3.00%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	22.42M	-62.09%
Dec 31, 2025	59.13M	-32.56%
Dec 31, 2024	87.67M	25.12%
Dec 29, 2023	70.07M	-46.02%
Dec 30, 2022	129.79M	-23.83%
Dec 31, 2021	170.40M	138.05%
Dec 31, 2020	Pro	Pro
Dec 26, 2019	Pro	Pro
Dec 26, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 23, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Provectus Biopharmaceuticals	21.64M
Anebulo Pharmaceuticals	19.71M
Harvard Apparatus Regenerative Technology	27.55M
Oncotelic Therapeutics	15.99M
Inhibitor Therapeutics	15.53M
HOOKIPA Pharma	14.15M
Zeo ScientifiX	14.00M
LianBio	13.20M

Market Cap Rankings